Company: INVUP
Filing Date: 2025-03-28
Form Type: 10-K
Source: 0001641172-25-001193
Chunk: 1585

Company: Investview, Inc.
Filing Date: 2025-03-28
Form: 10-K
Item: Item 2
Chunk 1585
---
 to offer investors an online
platform to enable self-directed retail brokerage and other related services.

Acquisition
of Business of Renu

On
October 11, 2024, we acquired substantially all of the business and assets of Renu Labs.
The total purchase price of Renu Labs was $1,780,000. As part of this acquisition, we also issued 5,000,0000 stock options to the principal
of Renu Labs, which options are scheduled to vest in equal amounts over a five-year period, at an exercise price of $0.05 per share with
a ten-year life.

Settlement
of Outstanding Matter with the SEC

During
November 2021, we received a subpoena from the United States Securities and Exchange Commission (“SEC”) for the production
of documents. The SEC order, the factual and legal findings of which we neither admit nor deny, relates to a program developed by prior
management involving the sale/leaseback of high-performance server equipment primarily used for bitcoin mining to investors from July
2019 through June 2020. In its order, the SEC concluded that the interests of the Company offered in connection with the program were
unregistered investment contracts sold in violation of Sections 5(a) and 5(c) of the Securities Act of 1933, as amended. On January 17,
2025, we reached an agreement and entered into a settlement with the SEC to resolve the inquiry. As part of the settlement, we agreed
to pay the SEC a penalty of $375,000 and to cease and desist from continuing any further violations of Sections 5(a) and 5(c) of the
Securities Act of 1933, as amended.

Amendment of Credit Arrangements with DBR
Capital

On
or about February 28, 2025, the Company and DBR Capital entered into an amendment to the Securities Purchase Agreement (the “Amendment”),
approved by the disinterested members of the Company’s Board of Directors. Pursuant to the Amendment, DBR has been given until
August 31,2025 to lend to the Company a minimum of $2.0 million, and until December 31, 2026 to lend to the Company balance of up to
$5.7 million. The Amendment also substantially reduces the interest rate for the first $2 million that may be advanced by DBR Capital
from 38.5% to 18.75% per annum, and further